David C. Weisman, MD

David C. Weisman, MD


David Weisman, M.D., received a BA in philosophy from Franklin and Marshall College, then an MD from Pennsylvania State College of Medicine. After an internship at St. Mary's Hospital in San Francisco, he completed neurology residency at Yale, where he served as Chief resident. He then went to University California, San Diego for fellowship training in Alzheimer's disease and other dementias. 

Dr. Weisman founded the Clinical Trial Center at Abington Neurological Associates and has been its director since 2008.  Over that time, Dr. Weisman has conducted numerous controlled clinical trials in treatment of mild cognitive impairment and Alzheimer’s disease.  Dr. Weisman has become a leading AD trialist nationwide.  The site has worked with nearly every major sponsor  and most major investigations since the late 2000s.  Theraputic mechanisms include monoclonal antibodies against amyloid and tau, beta secretase inhibitors and modulators, anti-fibrillization/anti-oligermerization agents, polytherapy, and a variety of symptomatic treatments.  Under his direction, the ANA Clinical Trial Center has become nationally recognized for testing these disease-modifying treatments.  Dr. Weisman was honored as an ADCS investigator.

His research focuses on clinical trials for the prevention and treatment of Alzheimer's disease, mild cognitive impairment, and other dementias; development and testing of biomarkers in Alzheimer’s disease; and studies advancing novel treatments in other conditions such as stroke, Parkinson's disease, Multiple Sclerosis and pain.  He lectures on dementia and is a proponent of an early diagnosis of and better therapies for Alzheimer's disease.  He invented, developed, and validated the Philadelphia Cognitive Exam, a computerized cognitive test and expert screening system to diagnose and detect dementia. 

Dr. Weisman has devoted his career towards advancing new therapies in Alzheimer's disease, stroke, multiple sclerosis, and Parkinson's disease.  He has been featured in the Philadelphia Inquirer for fighting on behalf of his patients. Dr. Weisman has published numerous scientific articles and abstracts. In the popular press, published pieces include Seed Magazine on Buddhism, Chronic Traumatic Encephalopathy and football, and the mind.  His technical scientific papers appear in the journals NeurologyArchives of Neurology, Stroke and Seminars in Neurology. His Alzheimer trial work collaborations have been published in Neurology, New England Journal of Medicine, and Archives of Neurology.